![Daniel Schmitt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Schmitt
Amministratore Delegato presso Actuate Therapeutics, Inc.
Patrimonio netto: 10 $ in data 30/04/2024
Profilo
Daniel M.
Schmitt's former job positions include Director-Academic Partnerships at First Genetic Trust, Inc. and SVP-Licensing & Commercial Development at Immtech Pharmaceuticals, Inc. He obtained his undergraduate degree and MBA from West Virginia University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
Actuate Therapeutics, Inc.
![]() Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. 2.63% | 01/05/2024 | 1 003 421 ( 2.63% ) | 10 $ | 30/04/2024 |
Posizioni attive di Daniel Schmitt
Società | Posizione | Inizio |
---|---|---|
Actuate Therapeutics, Inc.
![]() Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Amministratore Delegato | 01/03/2015 |
Precedenti posizioni note di Daniel Schmitt
Società | Posizione | Fine |
---|---|---|
First Genetic Trust, Inc.
![]() First Genetic Trust, Inc. Medical/Nursing ServicesHealth Services First Genetic Trust, Inc. provides genetic data handling and bioinformatics services to pharmaceutical companies, medical researchers and health care providers. The company was founded in 2000 by Arthur L. Holden and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Immtech Pharmaceuticals, Inc.
![]() Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formazione di Daniel Schmitt
West Virginia University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Immtech Pharmaceuticals, Inc.
![]() Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY. | Health Technology |
First Genetic Trust, Inc.
![]() First Genetic Trust, Inc. Medical/Nursing ServicesHealth Services First Genetic Trust, Inc. provides genetic data handling and bioinformatics services to pharmaceutical companies, medical researchers and health care providers. The company was founded in 2000 by Arthur L. Holden and is headquartered in Deerfield, IL. | Health Services |
Actuate Therapeutics, Inc.
![]() Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Daniel Schmitt